Injective: MiCA whitepaper for INJ filed and listed in ESMA's Interim Register - 25 Sep 2026

Injective has officially filed a MiCA-compliant whitepaper for its native token, INJ, which is now listed in the European Securities and Markets Authority (ESMA) Interim MiCA Register. This filing represents a critical procedural step toward establishing a harmonized regulatory framework for the asset across 30 European Union markets. By aligning with the Markets in Crypto-Assets (MiCA) regulation, Injective aims to provide European investors and institutional custodians with a clear compliance pathway for trading and holding the token. While the current listing in the register is a filing-stage milestone rather than final authorization, it significantly reduces the legal ambiguity that has previously deterred some European venues from supporting the asset. The move signals a broader trend of blockchain protocols proactively seeking regulatory clarity to facilitate institutional adoption within the EU. Future authorization outcomes will determine the extent to which exchanges can offer regulated access to INJ. This development underscores the growing importance of MiCA compliance as a prerequisite for scaling RWA and crypto-asset infrastructure in the European economic area.